De Benedetti VM - Search Results

1

p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.

De Benedetti VM, Travis LB, Welsh JA, van Leeuwen FE, Stovall M, Clarke EA, Boice JD Jr, Bennett WP. De Benedetti VM, et al. Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):93-8. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8850268

2

p53 tumor suppressor gene: implications for iatrogenic cancer and cancer therapy.

De Benedetti V, Bennett WP, Greenblatt MS, Harris CC. De Benedetti V, et al. Med Pediatr Oncol Suppl. 1996;1:2-11. Med Pediatr Oncol Suppl. 1996. PMID: 8643042 Review. No abstract available.

3

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.

Guinee DG Jr, Travis WD, Trivers GE, De Benedetti VM, Cawley H, Welsh JA, Bennett WP, Jett J, Colby TV, Tazelaar H, et al. Guinee DG Jr, et al. Among authors: de benedetti vm. Carcinogenesis. 1995 May;16(5):993-1002. doi: 10.1093/carcin/16.5.993. Carcinogenesis. 1995. PMID: 7767998

4

p53 is not mutated in hepatocellular carcinomas from Alaska Natives.

De Benedetti VM, Welsh JA, Trivers GE, Harpster A, Parkinson AJ, Lanier AP, McMahon BJ, Bennett WP. De Benedetti VM, et al. Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):79-82. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7894327

5

p53 mutations in hepatocellular carcinoma related to oral contraceptive use.

De Benedetti VM, Welsh JA, Yu MC, Bennett WP. De Benedetti VM, et al. Carcinogenesis. 1996 Jan;17(1):145-9. doi: 10.1093/carcin/17.1.145. Carcinogenesis. 1996. PMID: 8565124

6

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

Trivers GE, De Benedetti VM, Cawley HL, Caron G, Harrington AM, Bennett WP, Jett JR, Colby TV, Tazelaar H, Pairolero P, Miller RD, Harris CC. Trivers GE, et al. Among authors: de benedetti vm. Clin Cancer Res. 1996 Oct;2(10):1767-75. Clin Cancer Res. 1996. PMID: 9816128

7

Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status.

Andersson M, Wallin H, Jönsson M, Nielsen LL, Visfeldt J, Vyberg M, Bennett WP, De Benedetti VM, Travis LB, Storm HH. Andersson M, et al. Among authors: de benedetti vm. Int J Cancer. 1995 Nov 3;63(3):330-6. doi: 10.1002/ijc.2910630304. Int J Cancer. 1995. PMID: 7591226

8

Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride.

Trivers GE, Cawley HL, DeBenedetti VM, Hollstein M, Marion MJ, Bennett WP, Hoover ML, Prives CC, Tamburro CC, Harris CC. Trivers GE, et al. J Natl Cancer Inst. 1995 Sep 20;87(18):1400-7. doi: 10.1093/jnci/87.18.1400. J Natl Cancer Inst. 1995. PMID: 7658501

9

An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.

Soini Y, Chia SC, Bennett WP, Groopman JD, Wang JS, DeBenedetti VM, Cawley H, Welsh JA, Hansen C, Bergasa NV, Jones EA, DiBisceglie AM, Trivers GE, Sandoval CA, Calderon IE, Munoz Espinosa LE, Harris CC. Soini Y, et al. Carcinogenesis. 1996 May;17(5):1007-12. doi: 10.1093/carcin/17.5.1007. Carcinogenesis. 1996. PMID: 8640905

10

Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors.

von Brevern MC, Hollstein MC, Cawley HM, De Benedetti VM, Bennett WP, Liang L, He AG, Zhu SM, Tursz T, Janin N, Trivers GE. von Brevern MC, et al. Among authors: de benedetti vm. Cancer Res. 1996 Nov 1;56(21):4917-21. Cancer Res. 1996. PMID: 8895744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters